University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Clinical Performance of NIPT in Multiple Gestation Pregnancies

Completed

Conditions: Trisomy 21 in Fetus

Interventions: Device: MaterniT21 PLUS and GENOME Laboratory-Developed Tests

First Posted Date: 2020-07-28

Last Posted Date: 2022-12-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2000

Registration Number: NCT04488393

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Multimodal Imaging Outcome Measures for ALS (Image ALS)

Phase 1

Terminated

Conditions: ALS

Interventions: Drug: [11C]-PBR28

First Posted Date: 2020-07-28

Last Posted Date: 2022-04-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2

Registration Number: NCT04490096

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana

Not Applicable

Active, not recruiting

Conditions: HIV/AIDS
Stroke

Interventions: Other: Robot Therapy

First Posted Date: 2020-07-27

Last Posted Date: 2024-10-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT04488250

Locations: 🇧🇼
University of Botswana, Gaborone, Botswana
🇺🇸
Penn Medicine Rittenhouse, Philadelphia, Pennsylvania, United States

International CDKL5 Registry

Recruiting

Conditions: CDKL5 Deficiency Disorder (CDD)

First Posted Date: 2020-07-27

Last Posted Date: 2024-03-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 500

Registration Number: NCT04486768

Locations: 🇺🇸
University of Pennsylvania Orphan Disease Center, Philadelphia, Pennsylvania, United States

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

Phase 1

Completed

Conditions: Alzheimer Disease

Interventions: Device: Active TMS
Behavioral: CILT
Device: Sham TMS

First Posted Date: 2020-07-22

Last Posted Date: 2024-11-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 23

Registration Number: NCT04482179

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

Phase 2

Recruiting

Conditions: Inflammation
Naltrexone
Antiretroviral Treatment
Methadone
Immune Activation
Buprenorphine
Opioid-use Disorder
HIV-1-infection

Interventions: Drug: Buprenorphine/naloxone
Drug: XR-Naltrexone
Drug: Methadone

First Posted Date: 2020-07-21

Last Posted Date: 2024-07-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 225

Registration Number: NCT04480554

Locations: 🇻🇳
Go Vap Clinic, Ho Chi Minh City, Vietnam
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Abatacept for the Treatment of Giant Cell Arteritis

Phase 3

Recruiting

Conditions: Giant Cell Arteritis

Interventions: Drug: Placebo
Drug: Abatacept

First Posted Date: 2020-07-17

Last Posted Date: 2024-08-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 78

Registration Number: NCT04474847

Locations: 🇨🇦
St. Joseph's Healthcare, Hamilton, Ontario, Canada
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Hospital for Special Surgery, New York, New York, United States

and more 4 locations

Liposomal Bupivacaine in Shoulder Arthroscopy

Phase 3

Withdrawn

Conditions: Rotator Cuff Tears

Interventions: Drug: Liposomal bupivacaine
Drug: Bupivacaine with Dexamethasone Solution

First Posted Date: 2020-07-08

Last Posted Date: 2024-03-12

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04461028

Locations: 🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Phase 3

Completed

Conditions: Hepatorenal Syndrome

Interventions: Drug: Terlipressin

First Posted Date: 2020-07-07

Last Posted Date: 2024-10-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT04460560

Locations: 🇺🇸
Baylor Scott and White All Saints Medical Center, Fort Worth, Texas, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Piedmont Healthcare, Inc, Atlanta, Georgia, United States

and more 4 locations

Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder

Phase 2

Not yet recruiting

Conditions: Opioid Dependence

Interventions: Drug: Vivitrol
Drug: Brixadi

First Posted Date: 2020-07-01

Last Posted Date: 2024-11-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 200

Registration Number: NCT04454411

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy